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Abstract
Introduction: While there is a global consensus on monitoring Human Immunodeficiency Virus (HIV) treatment progress,
there has been less attention to the degree of consistency of the measurement of HIV prevention programmes—and the glo-
bal prevention response is not on-track to achieve 2020 goals. In this paper, we assess the degree of variability in primary pre-
vention indicators selected by national strategic plans (NSPs) and global stakeholder monitoring and evaluation (M&E)
strategies.
Methods: We obtained the most recent NSPs from low and middle income Joint United Nations Programme on HIV/AIDS
(UNAIDS) Fast-Track countries, and M&E documents from The Global Fund to Fight AIDS, Tuberculosis and Malaria (The Glo-
bal Fund), President’s Emergency Plan for AIDS Relief (PEPFAR), UNAIDS, the Global HIV Prevention Coalition and the World
Health Organization (WHO). We extracted HIV primary prevention indicators from each document, standardized and aggre-
gated them by age/ sex, categorized indicators by topic, and evaluated the frequency of matched indicators between countries
and stakeholders. Data were collected between February and April of 2019.
Results: Twenty-one NSPs and five global stakeholder documents were assessed; 736 primary prevention indicators were
identified; 284 remained following standardization and aggregation. NSPs contained from 3 to 48 primary prevention indica-
tors, with an average of 23; categories included: HIV education and outreach (17.6%), testing (17.3%) and condom use
(16.2%). Of unique national indicators, only 34% was shared between two or more countries. 69% was applied in a single
country only. 56% of NSP indicators did not appear in any global stakeholder document. Conversely, 42% of global indicators
did not appear in any surveyed NSPs. Within global indicators, 63% was only measured by one global body, and no single
indicator was measured by all five.
Conclusions: These analyses reveal a lack of consensus both between and within countries’ and global stakeholders’ measure-
ment of HIV prevention. Though some variability is expected, these findings point to a need to refocus attention on achieving
greater consensus on a global measurement framework for HIV prevention.
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1 | INTRODUCTION
Substantial progress has been made in responding to the HIV
epidemic over the past decade, with new HIV infections reduced
by an estimated 40% since their peak in 1996, and a 60%
decrease in Human Immunodeficiency Virus/Acquired Immunod-
eficiency Syndrome (HIV/AIDS)-related mortality since 2005 [1].
However, HIV remains a global public health threat. An esti-
mated 1.7 million people became newly infected with HIV in
2019, far above the United Nations General Assembly goal of
fewer than 500,000 new HIV infections in 2020 [1,2].
In recent years, there has been a focus on expanding
treatment access to improve patient outcomes and
decrease the risk of onwards transmission; however, in
some settings, there has been insufficient attention to pri-
mary HIV prevention. In 2012, after preventive benefits of
HIV treatment were confirmed by the HPTN052 trial,
models projected that HIV incidence would decrease by
35% to 54% within eight years in areas where population
coverage levels reached 80% [3]. However, declines of this
magnitude have not been observed in studies on a popula-
tion level in the test and treat trials, highlighting the
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continued need for evidence-based combination prevention
interventions [4-6].
One of the strengths of the treatment response is the clar-
ity of programmatic goals and indicators. The 2014 UNAIDS
90-90-90 targets (90% of all people living with HIV know
their status, 90% of all people with diagnosed HIV infection
will receive sustained antiretroviral therapy and 90% of all
people receiving antiretroviral therapy will have viral suppres-
sion by 2020) helped to streamline and prioritize monitoring
and evaluation efforts for treatment and arguably served as
an effective and powerful rallying and advocacy tool [7]. There
is strong global alignment behind these targets, from the U.S.
President’s Emergency Plan for AIDS Relief (PEPFAR), Joint
United Nations Programme on HIV/AIDS (UNAIDS), to The
Global Fund to Fight AIDS, Tuberculosis and Malaria and the
World Health Organization (WHO) [8-12]. Having a clear,
focused treatment target has mobilized and influenced these
decision makers, with substantial progress made in achieving
the targets since their launch [13,14].
Although there have been efforts to establish clear preven-
tion goals, such as the establishment of UNAIDS’s five pillars
[2], national governments and global stakeholders all have pro-
cesses to produce monitoring and evaluation indicators
[10,12]. There has been limited examination of the range of
prevention-related indicators in use and the degree to which
global stakeholders and governments are aligned in their mea-
surement. Without this understanding, it is difficult to under-
stand the feasibility and path forward to attain more
streamlined indicators and global targets.
In order to understand the degree of consensus in HIV pri-
mary prevention measurement and evaluation, we review the
variability in the primary prevention indicators selected in the
country national strategic plans (NSPs) and global monitoring
and evaluation documents. In addition, we examine the fre-
quency of categories of primary prevention indicators used
most consistently across stakeholders.
2 | METHODS
2.1 | Data collection
2.1.1 | Data collection in country NSPs
Countries were included for analysis if they were one of the
28 low/middle-income countries (LMIC) included in the
UNAIDS Fast Track list (Table 1) [15]. The 2015 UNAIDS Fast
Track list countries were selected for their need to accelerate
their HIV response in order to meet the global target of end-
ing AIDS by 2030. The 28 low/middle-income countries and
two high-income countries on the Fast Track list account for
89% of all new HIV infections [15]. This analysis included only
the low- and middle-income countries. The search strategy for
the NSP documents included an internet search of the coun-
try name, “HIV” and “National Strategic Plan” or “National
framework” or “Monitoring and Evaluation framework,” and
the Ministry of Health website for each country. Representa-
tives of each country’s Ministry of Health were contacted
through publicly available contact information found on the
website. Data were collected between February and April of
2019. The most recent publicly available NSPs were compiled
for each country. Any NSP that was published and applied (i.e.
years in scope) prior to 2014 were excluded. Indicators were
identified within each NSP by searching for tables containing
the term “indicator”; these were recorded and subsequently
evaluated based on inclusion/exclusion criteria.
2.1.2 | Selection of global bodies
Consultations with experts in the field of HIV prevention iden-
tified the following global monitoring and evaluation docu-
ments for review: The Global Fund HIV Monitoring &
Evaluation Framework (GF M&E) (2017), PEPFAR Monitoring,
Evaluation and Reporting (MER 2.0) Indicator Reference
Guide (2017), UNAIDS Global AIDS Monitoring (GAM)
(2018), UNAIDS Global HIV Prevention Coalition Indicators
(PC) (2017) and WHO Consolidated Strategic Information (SI)
Guidelines (2015) [8-12]. These documents were obtained
from each of the global organizations’ websites.
2.2 | Inclusion/exclusion criteria for indicators
Each indicator within each NSP and global stakeholder docu-
ment was reviewed and evaluated based on predefined inclu-
sion/exclusion criteria that are detailed in Table 1. All
indicators relevant to the primary prevention of incident HIV
infections were included. Indicators related to antiretroviral
treatment and prevention of mother to child transmission
(PMTCT) were excluded. HIV testing indicators were included
in the analysis because HIV testing is a necessary pre-condi-
tion for eligibility for most HIV prevention interventions, and
serves as the entry point to the prevention cascade.
Each indicator included in our study was categorized within
a measurement and evaluation indicator logical framework
[16]. Indicators were included if they were defined as “activi-
ties,” “outputs,” or “outcomes,” and excluded if defined as
“assessment and planning,” “inputs,” or “impacts” to capture
indicators relevant to primary prevention [16].
2.3 | Data extraction and indicator standardization
and aggregation
For each indicator, population type, age group (if available),
numerator and denominator was extracted and recorded.
These fields were then standardized across country NSP indi-
cator lists and global indicator lists on these fields, such that
exact language was not necessary to constitute a match. For
example “men who receive voluntary male medical circumci-
sion” and “men who undergo voluntary male medical circumci-
sion,” would be standardized to “men who receive voluntary
male medical circumcision.” Indicator language standardization
was performed by SS and confirmed by JD.
Following extraction and standardization from the reviewed
documents, indicators were aggregated by age and sex, to
minimize over-reporting of variability based on minor variation
in disaggregation of age and sex amongst nations and global
stakeholders. They were also combined if they measured “per-
cent of” or “number of”. For example if one country measured
“% of men aged 15 to 20 who are circumcised” and one global
body measured “# of men aged 30 to 39 who are circum-
cised” this would be considered a match between the country
and global body. However, indicators remained disaggregated
by key populations (defined groups who are at increased risk
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of HIV, in any context), priority populations (groups who are
at increased risk of HIV, in certain contexts) and other distinct
populations (Table 2).
2.4 | Data analysis
The indicators collected by each country were identified. For
each country, indicators were evaluated by whether they
appeared in any global stakeholder monitoring and evaluation
(M&E) document. The proportion of indicators not in any eval-
uated global stakeholder M&E documents was calculated, by
country and averaged across countries. The indicators listed
by countries were evaluated by whether they were present in
any global stakeholder prevention indicator set and the num-
ber of country NSPs. We conducted sub-analyses to examine
variability in NSP indicators within the high burden region of
Eastern and Southern Africa [17], and by countries with high
vs. low burdens (countries with “high” burdens have >1%
prevalence of HIV and countries with “low” burdens have <1%
prevalence of HIV) [18]. We also compared HIV prevalence
[18] to the number of indicators in a country NSP and calcu-
lated a Pearson’s correlation coefficient (r).
Similarly, the number of indicators identified by each global
stakeholder were compiled. Each global indicator was evalu-
ated by whether it was documented in any country NSP. For
each indicator, the number of countries that identified the
indicator, as well as the number of global stakeholders that
identified the indicator was assessed. The authors used Micro-
soft Excel (version 10) to house and analyse the extracted
data.
3 | RESULTS
Of the 28 2015 LMIC Fast-Track countries, the NSP for 24
(86%) were obtained (Table 2a). Of these, seven were
translated to English using online translation services: Angola
(Portuguese), Cameroon (French), Chad (French), China (Man-
darin), Cote d’Ivoire (French), Ukraine (Ukrainian) and Vietnam
(Vietnamese). The NSPs for Jamaica, Vietnam and China did
not include any indicators, so these three countries were also
excluded from the analysis leaving 21 countries to be
included. Documents were also evaluated for five global stake-
holders (Table 2b). In total, 736 unique primary prevention
indicators were extracted. After standardization and aggrega-
tion, 284 unique primary prevention indicators remained for
analysis.
3.1 | Indicator alignment between countries
The 21 NSPs (Table 3) contained 247 unique indicators. Of
these, 162 (66%) were measured by only one country. The
indicators with the most country-level consensus were (in
descending order of consensus):
-“%/# of general population who report testing in last
12 months and know test results” (13 countries),
-“%/# of general population who correctly identify main forms
of HIV transmission and reject incorrect ones” (12 countries)
-“%/# of general population who had more than one partner in
the last 12 months and report condom use at last sexual
encounter” (11 countries)
The NSPs of the 11 high burden HIV countries of Eastern
and Southern African included 158 indicators, with high vari-
ability between these countries; 107 (68%) of the indicators
were listed in only one NSP. Of the 235 indicators measured
by the 17 countries with high burden epidemics, 158 (67%)
were measured by only one NSP, and the most commonly
measured indicator (“%/# of general population who report
testing in last 12 months and know test results”) was included
in 11 NSPs. Of the 59 indicators measured by five countries
Table 1. Inclusion and aggregatiaon criteria
Inclusion criteria • Either all of the following:
a. Indicator is in a table labeled with the term "indicator"
b. Indicator is associated with HIV acquisition and incidence (including discrimination against people living with HIV and
sero-discordant couples)
c. Indicator is in "activity," "output," and "outcome" category of data collectiona
• Or, document categorizes indicator as a HIV prevention indicator
Exclusion criteria • Indicator is associated with mother-to-child transmission
• Indicator is in "assessment and planning," "inputs," or "impacts" category of data collectiona
Aggregation
criteria
• Indicators were aggregated by:
a. Age
b. Sex
c. Percent vs. number vs. percent/number
• Indicators remained disaggregated by:
a. Key populations: men who have sex with men, people who inject drugs, sex workers, transgender people, prisoners
b. Priority populations: adolescent girls and young women, mobile populations, non-injecting drug users, military
c. Other distinct populations: vulnerable populations, pregnant/breastfeeding women, sexual violence victims, people living
with HIV
a
Inputs – financial, human, or material resources used in a programme or intervention; Activities – actions taken or work performed through which
inputs are mobilized to produce outputs; Outputs – intermediate effects of an intervention’s outputs, such as change in knowledge, attitudes,
beliefs, behaviors; Impacts – the long-term, cumulative effects of programmes or interventions.
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with low HIV burdens, 42 (74%) were included in only one
NSP and only 2 (3.5%) indicators were measured by four
countries. Furthermore, only a weak positive correlation was
found when comparing the number of indicators and HIV
prevalence for each country (r = 0.30).
3.2 | Indicator alignment between global
stakeholders
The M&E guidance documents of the five global stakeholders
(Table 4) included 89 unique indicators. Of these, 56 (62.9%)
were included by only one stakeholder, seven were included
by four stakeholders and none were present in all five docu-
ments. The seven indicators included by four stakeholders
were (in alphabetical order):
-“%/# of general population who receive pre-exposure prophy-
laxis (PrEP)”
-%/# of men who have sex with men (MSM) who report con-
dom use during the last occurrence of anal sex”
-“%/# of MSM reached with programmes for HIV prevention”
-“%/# of people who inject drugs (PWID) reached with pro-
grammes for HIV prevention”
-“%/# of sex workers (SW) who report condom use with last
client”
-“%/# of SW reached with programmes for HIV prevention”
-“# of syringes distributed per PWID”
3.3 | Indicator alignment between countries and
global stakeholders
Figure 1 shows the number of HIV prevention indicators
included in NSPs within each country studied. The number of
















Angola 2015 to 2018 67 34 33
Cameroon 2014 to 2017 47 25 22
Chad 2012 to 2015 163 79 84
Cote
d’Ivoire




2014 to 2017 60 23 37
Ethiopia 2015 to 2020 23 9 14
India 2017 to 2024 61 41 20
Indonesia 2010 to 2014 29 11 18
Kenya 2014 to 2019 120 74 46
Lesotho 2014 to 2018 64 18 46
Malawi 2015 to 2020 70 36 34
Mozambique 2016 12 7 5
Nigeria 2017 to 2021 48 16 32
Pakistan 2015 to 2020 108 20 88
South Africa 2017 to 2022 104 47 57
Swaziland 2014 to 2018 96 39 57
Tanzania 2016 to 2018 74 46 28
Ukraine 2014 to 2018 28 17 11
Uganda 2015 to 2020 72 41 31
Zambia 2017 to 2021 69 37 32
Zimbabwe 2015 to 2018 27 13 14
Indicator count refers to indicators as listed on original document.

















2018 143 22 121
Global Fund
M&Eb
2017 75 25 50
PEPFAR
MERc





2017 17 1 16
WHO SId 2015 208 92 116
Indicator count refers to indicators as listed on original document.
a
Joint United Nations Programme on HIV/AIDS Global AIDS Monitor-
ing;
b
Global Fund HIV Monitoring & Evaluation Framework;
c
U.S. Presi-
dent’s Emergency Plan for AIDS Relief Monitoring, Evaluation and
Reporting Indicator Reference Guide;
d
World Health Organization
Consolidated Strategic Information Guidelines.
Table 3. Number of countries’ national strategic plans (NSPs)
that measure each unique HIV prevention indicator
Number of countries’ NSPs that measure
















Total unique indicators collected by countries 247
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indicators collected ranged from 3 (Mozambique) to 48
(Chad). The proportion of indicators collected by each country
that were included in any global stakeholder set ranged from
100% (Mozambique) to 20% (Cameroon). Averaging percent-
ages across all countries, 56% of indicators collected at the
country level did not appear in any of the evaluated global
M&E documents. Of the 247 unique indicators collected by
countries, 52 appeared in at least one global M&E document
(21.1%) and 195 did not appear in any global document
(78.9%).
The five global M&E documents (Figure 2) included 89
unique indicators. Of these, 52 (58.4%) were collected in at
least one country, whereas 37 (41.6%) did not appear in any
surveyed NSPs. By global stakeholder, the percentage of indi-
cators not appearing in any NSP ranged from 13% (Global
HIV Prevention Coalition) to 42% (GAM).
Tables S1 and S2 show global stakeholder indicators that
were absent from any surveyed NSP and indicators measured
by at least one surveyed NSP and at least one global
stakeholder respectively. Examples of global stakeholder indi-
cators absent from any surveyed NSP include:
-“%/# of general population diagnosed with gonorrhoea in past
12 months”
-“%/# of health units with PrEP services”
Examples of indicators measured by at least one surveyed
NSP and at least one global stakeholder include:
-“%/# of MSM who report testing in the last 12 months and
know test results”
-“%/# of PWID who report using sterilized equipment during
last needle use”
-“%/# of males circumcised”
3.4 | HIV prevention indicators by category
The categories with the most indicators were HIV education
and outreach (17.6%), testing (17.3%), condom use (16.2%),
stigma and discrimination (12.3%) and sexually transmitted
infections (STIs) (7.0%). Among countries, the most frequently
measured indicators by category were HIV education and out-
reach (19.0%), condom use (18.2%), testing (17.0%), stigma
and discrimination (9.7%) and STIs (5.7%). Proportions of indi-
cators in each category were similar by region and epidemic
type. Among global stakeholders, the most frequently mea-
sured indicators by category were testing (27.0%), stigma and
discrimination (14.6%), HIV education and outreach (13.5%),
condom use (7.9%) and STIs (6.7%).
However, outside the top five categories, there was rela-
tively little alignment in countries and global bodies in indica-
tor type measured (Figure 3). For instance South Africa’s NSP
and UNAIDS GAM were the only two documents that
included hormonal contraceptives in any indicator. Likewise,
four of the five global stakeholders (GAM, GF M&E, MER and
Table 4. Number of global stakeholders that measure each
unique HIV prevention indicator
Number of global stakeholders that measure








Total unique indicators collected by global
stakeholders
89
Figure 1. Number of HIV prevention indicators measured in the national strategic plan (NSP) of each country.Dark red bar indicates inclu-
sion of that indicator in one or more global stakeholder documents.
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SI) had indicators measuring alcohol and drug use, but only
four countries (Kenya, Pakistan, South Africa, Ukraine) had an
alcohol/drug-related indicator. HIV education and outreach
were the most commonly measured indicator category, with
90% (19/21) of countries (exceptions were India and Mozam-
bique) and all five global stakeholders having at least one edu-
cation/outreach indicator. Testing was the second most
commonly measured indicator, with almost all countries and
global stakeholders (exception: Ethiopia, Global HIV Preven-
tion Coalition) having at least one testing indicator. Condom
use was the third most commonly measured indicator cate-
gory and there were four or more indicators measuring it in
11 countries; every surveyed country and global body had an
indicator related to condom use, with the exception of two
countries (Nigeria and Ukraine) and PEPFAR MER. There was
high heterogeneity in the indicators’ specific language. For
example, there were 20 unique ways to measure condom use
amongst the surveyed NSPs and key global stakeholders. Fur-
thermore, countries with low HIV burden (Democratic Repub-
lic of Congo, India, Indonesia, Pakistan and Ukraine) had, on
average, 3.6 indicators on condom use and countries with high
HIV burden had, on average, 4.3 indicators on condom use.
4 | DISCUSSION
In order to understand the degree of consensus in HIV pri-
mary prevention measurement and evaluation, we reviewed
the primary prevention indicators included in national strate-
gic plans and global stakeholder M&E documents. Our review
found limited agreement between global stakeholders and
countries measurement of HIV prevention, with no indicators
measured by more than 13 of the 21 countries, and no indica-
tors measured by all five global stakeholders. There was a high
range (from 3 to 48) in the number of indicators measured
within each country and by global stakeholder (from 15 to
45). The number of indicators measured by each country was
only weakly correlated with HIV rate by country. The majority
(66%) of national indicators for HIV prevention were mea-
sured only by a single country; this heterogeneity amongst
countries remained even when comparing countries with simi-
lar epidemics and/or geographies. Similarly, 63% of indicators
in global stakeholder M&E documents was only measured by
one global stakeholder. Additionally, there was a high degree
of discordance between and within countries and global stake-
holders, with 56% of country indicators not appearing in any
of the evaluated global stakeholder M&E documents when
averaged across countries. There was also a high degree of
discordance in terms of prevention categories measured and
the number of indicators measured in each category.
Our findings suggest that global stakeholders need to har-
monize to a set of indicators that have a firm empiric basis,
are strongly linked to HIV prevention outcomes, are harmo-
nized across geographies to the extent possible, and meet the
rigour of a framework (e.g. the UNAIDS indicator framework)
[19]. Some degree of variability among global stakeholders,
among countries, and between global stakeholders and coun-
tries is expected for several reasons. First, there is hetero-
geneity in terms of how global stakeholder documents are
intended to be used. For example UNAIDS GAM is meant to
be for annual global reporting on outcome and impact indica-
tors, as defined by political declarations [10]. The Global HIV
Prevention Coalition aims to monitor national prevention pro-
grammes [11], and MER indicators reflect US government pri-
orities [9]. There is heterogeneity in reporting frequency (e.g.
some MER indicators are reported quarterly, some semi-annu-
ally and some annually). There are also differences in how
often indicators are modified, with WHO SI guidelines
updated every five years and Global Fund guidelines updated
every three years, whereas MER indicators are updated yearly
[8,12]. This variability in purpose naturally affects the variabil-
ity in indicators collected. This is true of NSPs as well. Kenya
Figure 2. Number of HIV prevention indicators measured by five global stakeholders.Dark red bar indicates inclusion of that indicator in
one or more countries’ National Strategic Plans. †Joint United Nations Programme on HIV/AIDS Global AIDS Monitoring. ‡Global Fund HIV
Monitoring & Evaluation Framework. §U.S. President’s Emergency Plan for AIDS Relief Monitoring, Evaluation, and Reporting Indicator Ref-
erence Guide. ¶World Health Organization Consolidated Strategic Information Guidelines.
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states that their NSP should be used to “track progress and
continuously measure results” and for “enhancing transparency
of all players,” whereas India’s NSP states that its aim is to
“provide a solid framework to tailor the response to local
needs based on context-specific evidence.” Second, countries
have different dynamics in their HIV epidemic and response,
and that variability could be reflected in their indicators. For
instance high burden countries may be focused on more gen-
eral populations and low-burden countries may focus more on
key populations. There are substantial differences in the
national HIV programmes and epidemiologic contexts of differ-
ent countries. Third, indicators that are also measured by
other programmes or sectors may not be reflected in HIV
NSPs; for instance STI-related indicators may be recorded in
Sexual and Reproductive Health monitoring and evaluation
plans. Finally, the process for creating NSPs and global stake-
holder documents varies by country and organization, with
some bodies implementing a more rigorous process than
others, engaging a wide range of stakeholders and experts,
whereas other processes are more ad-hoc or political. Mea-
suring prevention remains challenging because of the difficulty
identifying high-risk individuals, determining which prevention
interventions are effective, and then taking those interven-
tions to scale. Some variability in measurement is useful as it
provides complementary perspectives on the state of HIV pre-
vention, but attention is needed on where variability is
expected and where measurement should be aligned.
Despite some of the potential explanations for the lack of
consensus, the analysis suggests a general lack of global align-
ment on measurement priorities and approaches within HIV
prevention [20]. For example indicators measured by four of
five global stakeholders were primarily measurements of key
populations or PrEP, whereas the indicators most measured
by countries were on testing, condom use and HIV education
in general populations. There does not seem to be a clear
explanation for these differences, but does suggest discor-
dance and underscores the lack of a unified global prevention
response.
One example where variability was particularly stark was in
indicators that measure condom use. For example, Cote
d’Ivoire listed 11 out of 31 indicators in their NSP within in
the single category of condom use, whereas Nigeria and
Ukraine did not measure condom use at all. In addition, there
was a high variability in the language used between different
condom indicators at both the country and global levels.
Another notable example was in the measurement of stigma
and discrimination, which was one of the top five categories in
both countries and global stakeholders, yet had significant
heterogeneity and definitions used.
Heterogeneity in indicators and definitions can have real
costs; for example resources are required to collect indicators;
funding may be at risk if indicators are not collected. As an
example, the Norwegian Refugee Council found that if their
nine largest donors used the same financial reporting format,
the organization would save 11,000 hours per year on finan-
cial reporting [21]. Frontline health workers at health facilities
are often the most impacted by large numbers of indicators,
as described in an assessment performed by the WHO [22].
There are also costs at the programmatic level in terms of the
human and financial resources required to collect and report
large numbers of indicators [21]. This is especially the case in
the HIV response, in which there are multiple global stake-
holders and large financial investments. Of note, indicators
that focused solely on testing or treatment of people living
with HIV were not included in this analysis; the reporting bur-
den is broader than prevention indicators alone. Larger than
Figure 3. Number of HIV prevention indicators by subject collected by each country and global stakeholder.Number of indicators is repre-
sented by a heat map where dark red boxes indicate maximum number of indicators and white boxes indicate minimum number of indica-
tors in National Strategic Plans. †Joint United Nations Programme on HIV/AIDS Global AIDS Monitoring, ‡Global Fund HIV Monitoring &
Evaluation Framework, §U.S. President’s Emergency Plan for AIDS Relief Monitoring, Evaluation, and Reporting Indicator Reference Guide, X
The Global HIV Prevention Coalition, ¶World Health Organization Consolidated Strategic Information Guidelines.
Sekimitsu S et al. Journal of the International AIDS Society 2020, 23:e25645
http://onlinelibrary.wiley.com/doi/10.1002/jia2.25645/full | https://doi.org/10.1002/jia2.25645
7
necessary indicators sets, particularly those with varying defi-
nitions for similar indicators, are likely to result in poorer data
collection and challenges in assessing performance at the
national and global level.
National strategic plans and global stakeholder documents
can serve as a proxy for a country or global body’s priorities,
and some variability is expected and can be beneficial. Yet the
degree of heterogeneity between selected indicators seems to
indicate an opportunity to reevaluate and better understand
the process for prioritizing and selecting indicators for HIV
prevention at the national and global levels. The current
UNAIDS-led Monitoring Technical Advisory Group – the man-
date of which is to harmonize national and global HIV indica-
tors – should re-evaluate and strengthen the process of
selecting and prioritizing indicators for HIV prevention. Con-
comitantly, donors with reporting requirements should commit
to prioritizing alignment, and leverage existing metrics when-
ever possible (e.g. through the use of the UNAIDS Indicator
Repository) [23]. Greater alignment behind clearer and more
consistent goals and measurements could ultimately catalyse
action for more effective HIV prevention programmes.
5 | LIMITATIONS
The potential limitations of this study include the availability
and translation of surveyed NSPs. This analysis only includes
21 of 28 possible low-/middle-income 2015 Fast-Track coun-
tries, although the included NSPs account for over 90% of the
estimated burden of new infections among the 28 countries
[18]. Additionally, we assume that all NSPs and stakeholders
use similar definitions for key populations or programmes (e.g.
that the definition of “sex workers” is consistent across coun-
tries and global organizations). Furthermore, as mentioned
earlier, we anticipate that some of the differences may be
related to the differential timing of the development of the
NSPs and global stakeholder’s indicator sets, although we only
included recent sets (2014 and onward) to mitigate this to
the extent possible.
6 | CONCLUSIONS
Reaching ambitious global 2030 goals for ending the HIV epi-
demic will require a more effective HIV prevention response.
This analysis suggests that the measurement of HIV preven-
tion programmes is highly heterogeneous and can reasonably
be considered one of the factors impeding progress. The vast
number of indicators and their diverse formats create a high
burden of collection on national systems and reflects the lack
of clarity about priorities for HIV prevention in various set-
tings and the best indicators for measurement. If more effec-
tive HIV prevention programmes are to be developed, greater
attention to creating unified frameworks for measurement will
be an important part of the process.
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